Arteris (NASDAQ:AIP) Stock: Insider K Charles Janac Sells 100,000 Shares

Key Points

• CEO K. Charles Janac sold 100,000 Arteris shares at an average price of $23.82, generating $2.38 million. The sale covered tax-withholding obligations tied to vested equity awards and reduced his stake by 1.22% to 8.13 million shares.
• Arteris shares traded at $23.97, near the lower end of their 52-week range of $12.06 to $50.26. The company reported a quarterly loss of $0.10 per share, missing analyst estimates, despite revenue of $24.13 million exceeding expectations.
• Analysts remain generally positive, with six Buy ratings and one Sell rating, producing a “Moderate Buy” consensus and an average price target of $39.43—well above the current share price.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Janac sold 100,000 shares of the business's stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $23.82, for a total value of $2,382,000.00. Following the completion of the transaction, the chief executive officer owned 8,129,071 shares of the company's stock, valued at $193,634,471.22. This represents a 1.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

K Charles Janac also recently made the following trade(s):

• On Friday, October 2nd, K Janac sold 9,359 shares of Arteris stock. The shares were sold at an average price of $24.64, for a total value of $230,605.76.
• On Tuesday, September 1st, K Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $20.75, for a total value of $2,075,000.00.
• On Tuesday, August 4th, K Janac sold 26,106 shares of Arteris stock. The stock was sold at an average price of $31.97, for a total value of $834,608.82.
• On Monday, August 3rd, K Janac sold 73,894 shares of Arteris stock. The stock was sold at an average price of $30.00, for a total value of $2,216,820.00.

Arteris Stock Performance

Shares of NASDAQ AIP traded down $0.69 during trading on Monday, reaching $23.97. 784,618 shares of the company traded hands, compared to its average volume of 730,172. The firm has a 50 day simple moving average of $24.86 and a 200-day simple moving average of $28.55. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $1.18 billion, a PE ratio of -27.55 and a beta of 1.90. Arteris, Inc. has a 52-week low of $12.06 and a 52-week high of $50.26.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The company had revenue of $24.13 million for the quarter, compared to the consensus estimate of $23.48 million. Equities research analysts anticipate that Arteris, Inc. will post -0.68 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Versant Capital Management Inc boosted its holdings in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $56,000 after buying an additional 290 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Arteris in the second quarter worth about $53,000. Allworth Financial LP bought a new position in shares of Arteris in the second quarter worth about $87,000. Wellington Management Group LLP grew its position in shares of Arteris by 0.4% during the second quarter. Wellington Management Group LLP now owns 500,200 shares of the company's stock worth $24,305,000 after purchasing an additional 1,897 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in Arteris by 366.7% during the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company's stock valued at $66,000 after purchasing an additional 3,161 shares during the period. Hedge funds and other institutional investors own 64.36% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on AIP. Rosenblatt Securities restated a "buy" rating and issued a $38.00 price target on shares of Arteris in a research note on Friday, August 7th. Jefferies Financial Group raised Arteris from a "hold" rating to a "buy" rating and raised their target price for the stock from $35.00 to $50.00 in a research report on Friday, August 7th. Roth Capital started coverage on shares of Arteris in a research report on Tuesday, August 4th. They set a "buy" rating and a $40.00 price target for the company. Oppenheimer initiated coverage on shares of Arteris in a research note on Thursday, July 16th. They issued an "outperform" rating and a $40.00 price objective on the stock. Finally, Weiss Ratings upgraded shares of Arteris from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 21st. Six analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $39.43.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company's portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.